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Slug, a member of the Snail family of transcription factors, plays a crucial role in the regulation of epithelial-mesenchymal transition
(EMT) by suppressing several epithelial markers and adhesion molecules including E-cadherin. Recently, several studies have reported
Slug to be expressed in breast carcinoma, oesophageal carcinoma accompanied with shorter survival. In this study, we first
investigated expression of Slug mRNA in five colorectal carcinoma cell lines by reverse transcription–polymerase chain reaction.
Furthermore, we investigated Slug and E-cadherin expression by immunohistochemistry in 138 patients with colorectal carcinoma.
Slug mRNA was clearly expressed in four out of five colorectal carcinoma cell lines. Positive expression of Slug and E-cadherin was
observed in 37 and 58% of cases, respectively. The positive expression of Slug was significantly associated with Dukes stage and
distant metastasis (P¼0.0027 and 0.0007), and the positive expression of Slug had a significant impact on patient overall survival
(Po0.0001, log-rank test). Moreover, patients with positive expression of Slug and reduced expression of E-cadherin showed the
worst prognosis (Po0.0001, log-rank test). Multivariate analysis indicated that Slug expression was an independent prognostic factor.
These results suggest that positive Slug expression in colorectal carcinoma patients may become a significant parameter of poor
prognosis.
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Colorectal carcinoma is among the most frequent malignant
diseases worldwide, and is one of the leading causes of cancer-
related deaths (Friedlich and Stem, 2000). A significant number of
patients with colorectal carcinoma who undergo apparently
curative operation unfortunately develop local recurrence or
distant metastasis leading to shorter survival (Rosen et al, 1998).
Therefore, adjuvant therapy is needed after surgical resection for
such biologically aggressive colorectal carcinomas. For this reason
identification of factors that accurately predict prognosis in
colorectal carcinoma is strongly required. A deeper insight into
the carcinogenesis and the factors related to the aggressiveness of
colorectal carcinoma may be necessary for this requirement.
Several previous works have revealed that epithelial-mesenchymal
transition (EMT) plays a crucial role in the progression and
aggressiveness of colorectal carcinoma (Barker and Clevers, 2001;
Bates and Mercurio, 2005; Brabletz et al, 2005).
Slug (SNAI2), a member of the Snail family of zinc-finger
transcription factors was first identified in the neural crest and
developing mesoderm in the chick embryos (Nieto et al, 1994). It is
highly expressed in cells undergoing EMT in the developing chick
embryo, where it is critical in the formation of the primitive streak,
endocardial cushions, decondensing somites and in closure of the
palate. Recently, Snail family transcription factors have been
reported to repress E-cadherin expression, which mediates cell-
to-cell adhesion, and increase cancer invasion in various
malignancies (Battle et al, 2000; Cano et al, 2000). The Snail
transcription factors include Snail (SNAI1) and Slug both of which
have been implicited in various malignancies. For example,
previous work has revealed that Slug to be the in vivo repressor
of E-cadherin associated with poor prognosis in breast carcinoma
and oesophageal squamous cell carcinoma (Hajra et al, 2002;
Martin et al, 2005; Uchikado et al, 2005).
In colorectal carcinoma, it has been reported that there is a
frequent loss of E-cadherin, which the majority of them
(approximately 80%) are due to promoter hypermethylation
(Garinis et al, 2002). However, the remaining mechanisms that
control the loss of E-cadherin in colorectal carcinoma is not yet
well understood. Therefore, Snail transcription factors may be
involved in the regulation of E-cadherin in some of the colorectal
carcinomas. Moreover, there are only few reports concerning the
role of Snail family transcription factors in colorectal carcinoma.
Previous study revealed that Snail was positive in 78% of colorectal
carcinoma patients, however, the functional consequences of Snail
overexpression was not determined either biologically or clinically
in that study (Roy et al, 2005). Furthermore, to our knowledge,
there are no reports concerning the expression of Slug in colorectal
carcinoma.
The purpose of the present study was to examine the in vivo
significance of Slug in colorectal carcinoma and the correlation
between Slug and E-cadherin expression in colorectal carcinoma.
Also, to clarify whether Slug may be used as a novel parameter to
predict prognosis in colorectal carcinoma. Received 9 December 2005; revised 3 April 2006; accepted 8 May 2006
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Cell lines
The human colon adenocarcinoma cell lines (DLD1, HT29, WiDr,
Colo320DM, SW620) obtained from American Type Culture
Collection (Rockville, MD, USA). All the cell lines were maintained
in RPMI 1640 medium supplemented with 10% FCS, 1% penicillin
and streptomycin at 371Ci n5 %C O 2.
Reverse transcription-polymerase chain reaction
Total RNA from the cell lines were obtained using RNeasy Mini kit
(Qiagen, Tokyo, Japan) according to the manufacture’s instruc-
tions. Expression of Slug was examined by reverse transcription–
polymerase chain reaction (RT–PCR) with the use of the following
primers: forward 50-GTG ATT ATT TCC CCG TAT CTC TAT-30,
reverse 50-CAA TGG CAT GGG GGT CTG AAA G-30 (Yokoyama
et al, 2001). For control, b-actin cDNA was amplified. The
condition of PCR were: initial denaturing at 951C for 10min,
followed by 38 cycles of denaturing at 941C for 60s, annealing at
531C for 60s and extension at 721C for 90s. All PCR products were
visualized by electrophoresis and ethidium bromide staining in 2%
agarose gels. RT–PCR was performed in a triplicate.
Patients and tissues
Formalin-fixed and paraffin-embedded samples from primary
colorectal carcinoma (n¼138) were obtained from Department of
General Surgery, Chiba University Hospital, Japan, from 1996 to
2000. The patient age ranged from 26 to 85 years old. Patients who
underwent neoadjuvant therapy, treated by endoscopic mucosal
resection, and with carcinomas besides colorectal were excluded.
Written informed consent was obtained from each patient. Clinical
and pathological data were documented and entered into a specific
tumour registry after surgery and follow-up (Table 1). The median
follow-up period was 5.11 years. This study was designed as
historical prospective study.
Immunohistochemistry
The specimens were cut into 3-mm-thick sections, which were
mounted on glass slides. Immunohistochemical staining was
performed using labeled streptoavidine-biotin-peroxidase and
microwave antigen retrieval technique. Monoclonal antibody
against E-cadherin (Takara Biotechnology Inc., Takara, CA,
USA) and polyclonal antibody against Slug (D-19, Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA) were used in the study.
Working dilutions of E-cadherin and Slug were both 1:100. The
specificity and sensitivity of Slug antibody was confirmed by
Western blotting and RT–PCR (Data not shown). Negative
controls were performed by omission of the primary antibody.
The tissue sections were washed in water, counterstained with
Mayer’s haematoxylin. Immunohistochemistry was performed in a
duplicate.
Evaluation of immunohistochemistry
Expression of E-cadherin was determined as previous study
(Shiozaki et al, 1991). The tumour cells that stained as
strongly as normal epithelial cells were considered as preserved
expression, and those which exhibited weaker staining than
normal epithelial cells or completely showed negative staining
were considered as reduced expression. Expression of Slug
was determined as positive when cytoplasmic and/or perinuclear
staining was seen in more than 10% of the tumour cells
(Uchikado et al, 2005). Expression of Slug was considered
negative when no or less than 10% of the tumour cells were
stained. In the evaluation of these two molecules high-power
field ( 200) of 10 random areas (within the tumour) were
selected. Evaluation of immunohistochemistry was independently
performed by two investigators (MS and TS).
Statistical analysis
Overall survival rates were calculated according to the Kaplan–
Meier method. Differences between the groups were evaluated
using the w
2 test, Student’s t test, and the log-rank test. The
prognostic factors were examined by univariate and multivariate
analyses (Cox’s proportional hazards model). Results were
considered significant when Po0.05 was obtained. All the
statistical analyses were performed using SPSS 11.5 for Windows
(SPSS Inc., Chicago, IL, USA).
RESULTS
Expression of Slug mRNA in colorectal carcinoma cell lines
RT–PCR showed Slug mRNA expression in HT-29, WiDr,
Colo320DM, and SW620 but showed faint expression in DLD1.
SW620 showed the strongest expression among all the cell lines
(Figure 1).
Expression of Slug and E-cadherin in colorectal carcinoma
by immunohistochemistry
Slug was observed mainly in the cytoplasm of the tumour cells.
Expression of Slug was considered as positive in 37% of all patients
(51 of 138; Figure 2A and B). Slug was not expressed in the normal
mucosa (Figure 2B, Inset). Expression of E-cadherin was observed
on the cell membrane and borders of the cancer cells. E-cadherin
was considered as preserved in 58% of all patients (80 of 138;
Figure 2C and D).
Relationship between Slug and E-cadherin expression and
clinico-pathologic data
Slug expression was significantly associated with Dukes stage and
distant metastasis (P¼0.0027, 0.0007, respectively; Table 1). E-
cadherin expression was significantly associated with depth of
tumour, lymph node metastasis, and Dukes stage (P¼0.0103,
0.0069, and 0.0054, respectively; Table 1).
In the present study, Slug expression was not correlated with E-
cadherin expression (P¼0.3594, Table 2).
Prognostic value of Slug and E-cadherin expression in all
patients (Dukes ABD)
Patients with Slug positive expression (n¼51) survived signifi-
cantly shorter than those with negative expression (n¼87)
(Po0.0001; Figure 3A). Patients with reduced E-cadherin
(n¼58) survived significantly shorter than those with preserved
E-cadherin expression (n¼80) (P¼0.0066; Figure 3B). Patients
with combined Slug positive expression and reduced E-cadherin
expression (n¼24) survived significantly shorter than those with
other combinations (Po0.0001; Figure 3C).
Prognositic value of Slug and E-cadherin expression in
Dukes B, C patients
With regard to Dukes B, C patients (n¼84), patients with positive
Slug expression (n¼25) showed a significant shorter survival than
those with negative expression (n¼59) (P¼0.039; Figure 3D).
However, there was no statistical significance between patients
with reduced E-cadherin (n¼38) and preserved E-cadherin
patients (n¼46) (P¼0.5455; Figure 3E). Patients with combined
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(n¼11) survived significantly shorter than those with other
combinations (P¼0.0103; Figure 3F).
Univariate and multivariate analyses of survival
The univariate and multivariate analyses of factors related to
patient prognosis were performed in all patients (n¼138, Dukes
ABD). The univariate analysis showed: age, E-cadherin expres-
sion, Slug expression, lymph node metastasis, venous invasion,
lymphatic invasion, distant metastasis, and Dukes stage were
significantly associated with patient survival (Po0.05, Table 3). All
the variables, which showed Po0.05 by the univariate analyses
were used for multivariate analyses. Multivariate analysis using the
Cox’s proportional hazards model revealed that Slug expression,
E-cadherin expression, lymph node metastasis, and distant
metastasis were independent and significant prognostic factors
in all patients (n¼138, Dukes ABD) (Table 4).
Moreover, the multivariate analysis of survival with regard to
Dukes B, C patients (n¼84) revealed that expression of Slug was
Table 1 Slug and E-cadherin expression in relation to clinicopathologic findings
E-cadherin Slug
Preserved Reduced Positive Negative
Characteristics Total 80 (58.0%) 58 (42.0%) P 51 (37.0%) 87 (63.0%) P
Age 0.5068 0.8861
63.16712.09 62.58711.51 63.97712.90 63.35713.31 63.05711.39
Gender 0.0854 0.8082
Male 83 (60.1) 53 (66.3) 30 (51.7) 30 (58.8) 53 (60.9)
Female 55 (39.9) 27 (33.7) 28 (48.3) 21 (41.2) 34 (39.1)
Tumour location 0.1123 0.7425
Colon 89 (64.5) 56 (70.0) 33 (56.9) 32 (62.7) 57 (65.5)
Rectum 49 (35.5) 24 (30.0) 25 (43.1) 19 (37.3) 30 (34.5)
Histology 0.2878 0.7484
Well 28 (20.3) 16 (20.0) 12 (20.7) 8 (15.7) 20 (23.0)
Mod 75 (54.3) 48 (60.0) 27 (46.6) 30 (58.8) 45 (51.7)
Por 9 (6.5) 5 (6.3) 4 (6.9) 3 (5.9) 6 (6.9)
Others 26 (18.9) 11 (13.7) 15 (25.8) 10 (19.6) 16 (18.4)
pT 0.0103 0.1443
T1 10 (7.2) 10 (12.5) 0 (0.0) 2 (3.9) 8 (9.2)
T2 19 (13.8) 14 (17.5) 5 (8.6) 6 (11.8) 13 (14.9)
T3 86 (62.3) 45 (56.3) 41 (70.7) 30 (58.8) 56 (64.4)
T4 23 (16.7) 11 (13.7) 12 (20.7) 13 (25.5) 10 (11.5)
pN 0.0069 0.4604
N0 77 (55.8) 51 (63.8) 26 (44.8) 29 (56.9) 48 (55.2)
N1 47 (34.1) 26 (32.5) 21 (36.2) 15 (29.4) 32 (36.8)
N2 14 (10.1) 3 (3.7) 11 (19.0) 7 (13.7) 7 (8.0)
pM 0.0664 0.0007
M0 108 (78.3) 67 (83.8) 41 (70.7) 32 (62.7) 76 (87.4)
M1 30 (21.7) 13 (16.2) 17 (29.3) 19 (37.3) 11 (12.6)
Dukes 0.0054 0.0027
A 24 (17.4) 21 (26.3) 3 (5.2) 7 (13.7) 17 (19.5)
B 45 (32.6) 27 (33.7) 18 (31.0) 17 (33.3) 28 (32.2)
C 39 (28.3) 19 (23.8) 20 (34.5) 8 (15.7) 31 (35.7)
D 30 (21.7) 13 (16.2) 17 (29.3) 19 (37.3) 11 (12.6)
Lymphatic invasion 0.6164 0.1486
Negative 75 (54.3) 45 (56.3) 30 (51.7) 23 (45.1) 52 (59.8)
Positive 61 (44.2) 34 (42.5) 27 (46.6) 26 (51.0) 35 (40.2)
Unknown 2 (1.5) 1 (1.2) 1 (1.7) 2 (3.9) 0 (0.0)
Venous invasion 0.8944 0.1189
Negative 97 (70.2) 56 (70.0) 41 (70.7) 31 (60.8) 66 (75.9)
Positive 39 (28.3) 23 (28.8) 16 (27.6) 18 (35.3) 21 (24.1)
Unknown 2 (1.5) 1 (1.2) 1 (1.7) 2 (3.9) 0 (0.0)
Slug
-Actin
DLD1            HT29           WiDr        Colo320        Sw620
Figure 1 Expression of Slug mRNA in colorectal carcinoma cell lines;
DLD1, HT29, WiDr, Colo320DM, SW620. Reverse transcription-poly-
merase chain reaction was performed and PCR product samples were
subjected to 2% agarose gel electrophoresis and visualized by staining with
ethidium bromide.
Slug expression in colorectal carcinoma patients
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expression of E-cadherin, lymph node metastasis, lymphatic
invasion, and vessel invasion (Table 5).
DISCUSSION
Carcinoma is a complex disease of differentiation, tissue
organization, and altered growth. These cellular activities are
important for normal embryonic development and maintenance of
proper function and structure of the mature organism. When these
factors disrupt, as evidenced in carcinoma, it results in loss of
tissue differentiation and facilitates invasion and metastasis. The
EMT plays an important role in the acquisition of invasive and
aggressive phenotype of carcinoma. Therefore, loss of expression
of epithelial markers and adhesion molecules including E-cadherin
is important in cancer progression and development. Indeed
several studies have clarified the role of EMT in metastasis of
colorectal carcinoma (Barker and Clevers, 2001).
Recently family of the Snail transcription factors (Slug and/or
Snail) has been found to repress E-cadherin and contribute to
tumour progression in various malignancies such as hepatocellular
carcinoma (Sugimachi et al, 2003; Miyoshi et al, 2004), breast
carcinoma (Hajra et al, 2002), melanoma (Poser et al, 2001), oral
squamous cell carcinoma (Yokoyama et al, 2001), and oesophageal
squamous cell carcinoma (Uchikado et al, 2005).
In colorectal carcinoma, previous study revealed that reduction
of E-cadherin is seen approximately in 38–46% of the patients
accompanied by significant poor survival, which is consistent in
part with our present study (Mohri, 1997; Ghadimi et al, 1999;
Karatzas et al, 1999; Ikeguchi et al, 2000; Aoki et al, 2003).
Furthermore, it has been reported that majority of the E-cadherin
reduction (approximately 80%) is due to promoter hypermethyla-
tion but not as a result of mutations or LOH at the E-cadherin gene
locus in colorectal carcinoma (Hyas et al, 1997, Garinis et al, 2002).
Present study showed reduction of E-cadherin was significantly
correlated with tumour stage, lymph node metastasis, and
advanced Dukes stage (Table 1). Also, multivariate analysis among
all the patients (Dukes ABD, n¼138) revealed reduction of
E-cadherin as one of the independent prognostic factors (Table 4).
Figure 2 An immunohistochemical analysis for Slug and E-cadherin in colorectal carcinoma. (A) Positive expression of Slug in the tumour cells ( 200).
(B) Negative expression of Slug in the tumour cells ( 200). Inset, negative staining in the normal mucosa ( 200). (C) Preserved E-cadherin expression is
detected at the cell–cell borders and the cell membrane ( 200). (D) Example of reduced expression of E-cadherin ( 200).
Table 2 Comparison of Slug expression and E-cadherin expression
E-cadherin expression
Slug expression Preserved (n¼80) Reduced (n¼58) P
Positive (n¼51) 27 24 0.3594
Negative (n¼87) 53 34
Slug expression in colorectal carcinoma patients
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sHowever, E-cadherin reduction showed no statistical significance
in the overall survival with regard to Dukes B, C patients (n¼84)
in our study (Figure 3E).
In the present study, we first examined the expression of Slug
mRNA in vitro using five human colorectal carcinoma cell lines.
The result that four out of five cell lines (HT29, WiDr, Colo320DM,
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Figure 3 (A) Overall survival of all patients (Dukes A–D) in relation to the expression of Slug (Po0.0001). (B) Overall survival of all patient’s (Dukes A–
D) in relation to the expression of E-cadherin (P¼0.0066). (C) Overall survival of all patient’s (Dukes A–D) in relation to the combination of Slug and E-
cadherin expression (Po0.0001). (D) Overall survival of Dukes B, C patient’s in relation to the expression of Slug (P¼0.0002). (E) Overall survival of Dukes
B, C patient’s in relation to the expression of E-cadherin (P¼0.5455). (F) Overall survival of Dukes B, C patient’s in relation to the combination of Slug and
E-cadherin expression (P¼0.0103). Slug(þ); positive expression of Slug, Slug( ); negative expression of Slug, E-cad(þ); preserved E-cadherin expression,
E-cad( ); reduced E-cadherin expression.
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investigate the in vivo expression of Slug in colorectal carcinoma.
Immunohistochemical staining revealed that Slug was positively
expressed in 37% of the patients, which was significantly
associated with distant metastasis and Dukes stage. Furthermore,
the overall survival of patients with Slug positive expression was
significantly poorer than those with negative expression. These in
vivo results seems to support our in vitro study that SW620
showed the strongest expression of Slug mRNA, because SW620 is
an aggressive metastatic colorectal carcinoma cell line (Trainer
et al, 1988).
Although expression of Snail was not investigated in the present
study, previous study revealed that positive expression of Snail was
seen in a majority of colorectal carcinoma patients (78%), which
showed no significant correlation with any of the clinicopatholo-
gical factors except the patient’s age (Roy et al, 2005). These
findings may suggest that transcription factor Slug rather than
Snail plays a crucial role in tumour invasion, metastasis, and
progression of colorectal carcinoma and may contribute to
aggressive phenotype. Moreover, the result that majority of
colorectal carcinoma express Snail and those with aggressive
behaviour express Slug, implies that Snail upregulation may be
involved in the early progression phase, and Slug upregulation
may be acquired in the latter progression phase of colorectal
carcinogenesis. The biological difference and role of Slug and Snail
in colorectal carcinoma needs to be clarified in the future.
To our knowledge, this is the first report concerning the clinical
significance of Slug expression in colorectal cancer. In the present
study, although Slug was detected in some tumours where E-
cadherin expression was decreased, positive Slug expression was
not correlated with reduced E-cadherin expression. This may be
because in colorectal casrcinoma the majority of E-cadherin
reduction is due to promoter hypermethylation (Garinis et al,
2002). On the other hand, previous study using a melanoma cell
line showed mutated E-cadherin cause downregulation of Slug in
vitro (Laux et al, 2004). The relationship between Slug expression
and tumour associated E-cadherin reduction in colorectal
carcinoma needs further investigation.
Our results suggest that Slug itself may participate in progres-
sion and aggressiveness of colorectal carcinoma, not just owing to
the repression of E-cadherin. In the previous study, Slug has been
reported to have an antiapoptotic effect on leukaemia cells and
breast carcinoma cells (Inukai et al, 1999; Hemavathy et al, 2000;
Kajita et al, 2004) and is capable to down regulate several epithelial
markers involved in cell–cell adhesion such as cytokeratin18,
muc-1, desmoplakin, occludin, and claudin-1 (Cano et al, 2000;
Guaita et al, 2002; Kajita et al, 2004; Martinez-Estrada et al, 2005).
Moreover, previous study has shown that Slug-overexpressing
mice developed mesenchymal tumours, mainly leukaemias and
sarcomas (Perez-Mancera et al, 2005). These findings indicate that
Slug plays a certain role in the carcinogenesis of mesenchymal
tumours and is capable to contribute to the invasiveness of human
malignancies not just by repressing E-cadherin but implicating in
EMT accompanied by downregulation of several epithelial markers
and enhanced cell survival.
In the present study, tumours with both increased expression of
Slug and reduced expression of E-cadherin showed the worst
prognosis, and the tumours with the opposite expression showed
the best prognosis. Although the patient samples included in the
present study were limited, univariate and multivariate analyses
revealed Slug to be an independent prognostic factor in colorectal
carcinoma patients. Furthermore, with regard to Dukes B and C
patients, multivariate analysis revealed Slug to be the only
independent prognostic factor. These results strongly indicate that
Slug expression might be a novel parameter to predict prognosis
for the aggressiveness of colorectal carcinoma and the combina-
tion of Slug and E-cadherin expression might give us precise
prognostic information in colorectal carcinoma including those
which curative operation have been performed. Expression of Slug
may also provide useful information in selecting patients who need
adjuvant therapy and strict surveillance. Slug may be an attractive
target for the treatment of colorectal carcinoma.
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